He et al. [62] demonstrated that APS (100–400 mg/kg) could inhibit liver cancer growth by reducing PD-L1 expression and PD-L1-mediated immunosuppression, with IC50 equal to 4.2 mg/mL. This evidence concerns the gene CD274 and liver cancer.